Stenting for small coronary vessels: a contestable winner*
Adnan Kastrati, MD*,a,
Helmut Schühlen, MD, FACCa and
Albert Schömig, MDa
a Deutsches Herzzentrum and I. Medizinische Klinik rechts der Isar, Technische Universität München, Munich, Germany

View larger version (19K):
[in a new window]
|
Figure 1 Relative risk for angiographic restenosis at six months, calculated for stents versus percutaneous transluminal coronary angioplasty (PTCA). These data are shown for all seven randomized trials mentioned in the text. Data are illustrated with the respective 95% confidence interval, represented by the horizontal bar. *Heparin-coated.
|
|

View larger version (24K):
[in a new window]
|
Figure 2 This graph illustrates the correlation between the difference in restenosis rates (data for percutaneous transluminal coronary angioplasty [PTCA] arm data for stent arm), as an indicator of the benefit with stenting, and the final diameter stenosis achieved in the PTCA arm, as an indicator of the quality of the PTCA procedure.
|
|
|